PATENT CLAIM ANALYSIS

Application Number: 16048933
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "312000"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for treatment of all symptoms of gastroparesis in a human patient, the method comprising administering to the human patient between about 0.5 mg/day to about 30 mg/day, about 0.5 mg/day to about 15 mg/day, about 0.5 mg/day to about 5 mg/day, or about 5 mg/day, of velusetrag or a pharmaceutically-acceptable salt thereof.

Claim (Index 36):
The method of  claim 34 , wherein the parenteral administration is percutaneous.

Metadata:
- Claim Count in Document: 91.0
- Percentile: 95.0
- Lexical Diversity: 1.81081
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13179315', '13181499', '15187751', '14307195', '14940431']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7126731196552967
- 35 USC 102 Novelty (BERT): 0.5275750861583071
- Combined Prediction Score: 0.6941633163055978
- Mean Citation Score: 238.93831
- Max Citation Score: 244.4096
- Similarity Product: 126.6467711097717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test